Sarcoma Oncology Research Center, LLC.

Santa Monica, California 90403

2 studies enrolling now · 13 studies all time

What they study most

Adult Solid Tumor, Advanced Solid Tumors, Breast Cancer, Carcinoma of Breast, Cholangiocarcinoma, Chondrosarcoma, Chordoma, Colorectal Cancer, Dedifferentiated Liposarcoma, Giant Cell Tumor of Bone, Head and Neck Neoplasms, Hepatotoxicity

Studies at this site

• A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment — Recruiting now
• A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100) — Completed
• Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) — Running, not enrolling
• BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast — Available (expanded access)
• AMG 404 in Patients With Advanced Solid Tumors — Completed
• Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma — Stopped early
• Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004 — Completed
• Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients — Completed
• Study of AMG 650 in Adult Participants With Advanced Solid Tumors — Completed
• Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors — Completed
• Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor — Completed
• Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax — Completed
• Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma — Status unconfirmed